CoChat

Smoking and antidepressants pharmacokinetics: a systematic review

Open access
Oliveira, Pedro, Ribeiro, Joana, Donato, Helena, Madeira, Nuno · 2017 · Annals of General Psychiatry

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Despite an increasingly recognized relationship between depression and smoking, little is known about how smoking influences antidepressant response and treatment outcomes. The aim of this study was to systematically review the evidence of the impact of smoking on new-generation antidepressants with an emphasis on the pharmacokinetic perspective. METHODS: We present a systematic review of clinical trials comparing the serum levels of new-generation antidepressants in smokers and nonsmokers. Data were obtained from MEDLINE/PubMed, Embase, and other sources. Risk of bias was assessed for selection, performance, detection, attrition, and reporting of individual studies. RESULTS: Twenty-one studies met inclusion criteria; seven involved fluvoxamine, two evaluated fluoxetine, sertraline, venlafaxine, duloxetine or mirtazapine, and escitalopram, citalopram, trazodone and bupropion were the subject of a single study. No trials were found involving other common antidepressants such as paroxetine or agomelatine. Serum levels of fluvoxamine, duloxetine, mirtazapine and trazodone were significantly higher in nonsmokers compared with smokers. CONCLUSIONS: There is evidence showing a reduction in the concentration of serum levels of fluvoxamine, duloxetine, mirtazapine and trazodone in smoking patients as compared to nonsmokers. The evidence regarding other commonly used antidepressants is scarce. Nonetheless, smoking status should be considered when choosing an antidepressant treatment, given the risk of pharmacokinetic interactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12991-017-0140-8

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 PRISMA flow diagram of the study selection process
Fig. 1 PRISMA flow diagram of the study selection processCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Bastos H, Polido F, Saraiva C. História da Psiquiatria. In: Saraiva C, Cerejeira J, editors. Psiquiatria fundamental. Coimbra: Lidel Edições Técnicas; 2014.

Cited by

See all 60

Metadata

Authors
Oliveira, P., Ribeiro, J., Donato, H., & Madeira, N.
Affiliations
Unidade Local de Saúde de Coimbra (PT)
Corresponding author
Madeira, Nuno
Venue
Annals of General Psychiatry
Published
2017-03-06
Volume
16
Issue
1
Pages
17-17
ISSN
1744-859X (ISSN-L)
OpenAlex
W2593668513
Cited by
60
References
41
Citations by year
2026: 5 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 1
FWCI
1.09
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Annals of General Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
smoking, antidepressants, pharmacokinetics, drug interactions, depression, fluvoxamine, duloxetine, mirtazapine, trazodone, fluoxetine, sertraline, venlafaxine, escitalopram, citalopram, bupropion, serum drug concentration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smoking and antidepressants pharmacokinetics: a systematic review. https://app.cochat.ai/papers/10.1186/s12991-017-0140-8
The paper
Oliveira, P., Ribeiro, J., Donato, H., & Madeira, N. (2017). Smoking and antidepressants pharmacokinetics: a systematic review. Annals of General Psychiatry. https://doi.org/10.1186/s12991-017-0140-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.